Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report

Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented with EON, only 6 days after initiation of rituximab therapy, notable...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Blessie Elizabeth, Tipton, Shelby, Venkatesan, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256914/
https://www.ncbi.nlm.nih.gov/pubmed/34267851
http://dx.doi.org/10.14740/jh814
_version_ 1783718193938825216
author Nelson, Blessie Elizabeth
Tipton, Shelby
Venkatesan, Rohit
author_facet Nelson, Blessie Elizabeth
Tipton, Shelby
Venkatesan, Rohit
author_sort Nelson, Blessie Elizabeth
collection PubMed
description Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented with EON, only 6 days after initiation of rituximab therapy, notable for the shortest duration to EON ever reported in literature. Throughout this paper, we explore the potential pathogenesis and incidence of EON with the help of our unique case.
format Online
Article
Text
id pubmed-8256914
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-82569142021-07-14 Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report Nelson, Blessie Elizabeth Tipton, Shelby Venkatesan, Rohit J Hematol Case Report Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented with EON, only 6 days after initiation of rituximab therapy, notable for the shortest duration to EON ever reported in literature. Throughout this paper, we explore the potential pathogenesis and incidence of EON with the help of our unique case. Elmer Press 2021-06 2021-06-16 /pmc/articles/PMC8256914/ /pubmed/34267851 http://dx.doi.org/10.14740/jh814 Text en Copyright 2021, Nelson et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Nelson, Blessie Elizabeth
Tipton, Shelby
Venkatesan, Rohit
Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
title Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
title_full Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
title_fullStr Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
title_full_unstemmed Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
title_short Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
title_sort early onset neutropenia due to rituximab therapy in mantle cell lymphoma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256914/
https://www.ncbi.nlm.nih.gov/pubmed/34267851
http://dx.doi.org/10.14740/jh814
work_keys_str_mv AT nelsonblessieelizabeth earlyonsetneutropeniaduetorituximabtherapyinmantlecelllymphomaacasereport
AT tiptonshelby earlyonsetneutropeniaduetorituximabtherapyinmantlecelllymphomaacasereport
AT venkatesanrohit earlyonsetneutropeniaduetorituximabtherapyinmantlecelllymphomaacasereport

Ejemplares similares